Where does Interrad Medical, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Interrad Medical, Inc. ranks #4,520 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Interrad Medical, Inc. hold?

Interrad Medical, Inc. holds 78 US utility patents granted between 2015 and 2025, spanning 3 technology areas.

What is Interrad Medical, Inc.'s Innovation Score?

Interrad Medical, Inc. has an Innovation Score of 37.8 out of 100 (top 43% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Interrad Medical, Inc.'s patent grant rate increasing or decreasing?

Interrad Medical, Inc.'s recent grant velocity is -22% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Interrad Medical, Inc.'s patents?

Interrad Medical, Inc.'s patents average 19.3 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Interrad Medical, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Interrad Medical, Inc.

Q: What technology areas does Interrad Medical, Inc. focus on?

Interrad Medical, Inc.'s top technology area is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor) with 75 patents, ranking #100 of 3,490 assignees active in that subclass. Grants appear in 3 CPC subclasses total.

USPTO PatentsView assignee record - 78 granted patents across 3 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Interrad ranks #4,520 of 49,997 tracked US assignees by granted-patent volume, with 78 patents across 3 technology areas.

#4,520
of 49,997 US assignees by volume: Top 43%
by Innovation Score (37.8/100): 19.3
avg claims per patent: -22%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R4520 · US Corporation #4,520 · 78 grants

GRANTS-SMALL · TOP-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DOWN · BOOK-FULL

GRANTS-SMALL 78 grants
TOP-DECILE #4,520/49,997
PHOTO-FINISH Hanchett Entry Systems
CPC-NARROW A61M · 3 areas
INNOV-THIN 37.8/100
CLAIMS-RICH 19.3 claims/avg
TYPE-USCORP US Corporation
VEL-DOWN -22% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Hanchett Entry Systems, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Interrad’s 37.8 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 15.1 pts (40%) Velocity 5.0 pts (13%) Breadth 6.1 pts (16%) Claim depth 11.6 pts (31%)

Qualcomm Incorporated · highest

85
Episurf Ip-managemen… · near

38
FKA Distributing · near

38
Interrad Medical · this assignee

38
Meyn Food Processing… · near

38
Shoei · near

38
3D Lighting… · lowest

7

What this shows Interrad's Innovation Score is 37.8/100 (top 43% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Interrad?

Each dot is one of Interrad’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Interrad’s own 19.3 claims/patent is ABOVE the 14.9 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Interrad vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Interrad's grants concentrate

Interrad Medical, Inc. is a focused PatentsView assignee: 3 CPC subclasses with 96.2% of grants classified under A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor). Peak complete grant year is 2019 (10 grants) versus a trough of 4 in 2024. By volume, Interrad sits between Hongfujin Precision Electronics (ZHENGZHOU) Co., Ltd. and Marmon Foodservice Technologies, Inc..

Interrad's three-year grant acceleration

From 2019–2021 to 2022–2024, Interrad Medical, Inc. moved from 24 to 18 grants (0.75x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.

Hongfujin Precisi…

78
Hanchett Entry Sy…

78
Heptares Therapeu…

78
Indian Institute…

78
KAO Germany

78
Keygene

78
Leonhard Kurz Sti…

78
Marmon Foodservice

78
Interrad Medical ◀

78

What this shows Interrad holds 78 patents at rank #4,520, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Interrad

By rank, the assignees closest to #4,520 in granted patent volume.

Leaders in A61M (Devices FOR Introducing Media Into)

Other assignees with the most granted patents in Interrad's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Interrad, neither rank-band nor same-CPC leaders (those blocks stay above). In A61M (Devices FOR Introducing Media Into), Interrad ranks #100 of 3,490 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (38 here).

Shoei Co., Ltd. 38 Meyn Food Processing Technology B.V. 38 FKA Distributing Co., LLC 38 Episurf Ip-management AB 38

Similar claim depth

Nearest assignees by average claims per patent (19.3 here).

ThoughtSpot, Inc. 19.3 avg The Travelers Indemnity Company 19.3 avg Carlisle Fluid Technologies, LLC 19.3 avg Cytiva BioProcess R&D AB 19.3 avg

Interrad's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

38 Top 43% higher than 57% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Interrad Medical, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	7	9.0%
2016	9	11.5%
2017	8	10.3%
2018	7	9.0%
2019	10	12.8%
2020	7	9.0%
2021	7	9.0%
2022	5	6.4%
2023	9	11.5%
2024	4	5.1%
2025partial year	5	6.4%

Which technologies does Interrad Medical, Inc. patent most?

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 75

A61B - DIAGNOSIS; SURGERY; Identification 25

Y10S - Technical Subjects Covered BY Former Uspc Cross-reference ART Collections [XRACs] AND Digests 6

Top 3 of 3 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Interrad Medical, Inc.'s patent record in context - here's where to go next.

Interrad Medical, Inc.'s lead technology class is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor), 96.2% of its portfolio - see every assignee active in that class. Explore A61M
Ranked #4,520 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Interrad Medical, Inc. against Hongfujin Precision Electronics (ZHENGZHOU) Co., Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 37.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.